MCI Onehealth Announces Changes to Management Team Structure
TORONTO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. ("MCI" or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, today announced that Jennifer Foster has departed the Company in connection with changes to the Company’s management team structure that have eliminated the position of Chief Operating Officer.
“We would like to thank Jennifer for her leadership and commitment to MCI as we navigated through a number of critical changes and we wish her all the best in her future endeavours,” said Dr. George Christodoulou, Co-Chair.
The Company has also transitioned Madeline Walker from her former position as President – Corporate Health Solutions to a new role as President – MCI Medical. The Company will shift some of the responsibilities previously associated with its Chief Operating Officer role over to its Chief Executive Officer, Chief Financial Officer and to the President – MCI Medical.
About MCI:
MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canada’s leading primary care networks with approximately 280 physicians and specialists, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including online visits via . MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. MCI provides data insights as a service in six categories: rare disease; complex major medical/chronic; patient cohort building; clinical trial recruitment; synthetic health data and bespoke insights. Led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement the company’s current roadmap. For more information, visit .
For media enquiries please contact:
Nolan Reeds |
Forward-Looking Statements
This press release contains forward-looking information and forward-looking statements (together, “forward-looking statements”) within the meaning of applicable securities legislation, which reflect MCI’s current expectations regarding future events, including statements relating to the redistribution of the responsibilities previously associated with the Company’s COO. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of words or phrases such as “may”, “could”, “would”, “might” or “will”. Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond MCI’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Such risks and uncertainties include execution risk, market risk, industry risk, the impact of general economic conditions and competition from other industry participants, stock market volatility, changes in personnel and senior management, the availability of financing and liquidity to support the Company’s ongoing operations and business plan, and other risks which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward‐looking statements and other factors discussed under “Risk Factors” in the Company’s annual information form for the year ended December 31, 2021 which is available under the Company’s profile on SEDAR at All forward-looking statements made in this press release are made as of the date hereof and MCI does not undertake any obligation to update such forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
